Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has received a consensus rating of “Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Ten investment analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have issued a report on the stock in […]
Syndax Pharmaceuticals (NASDAQ:SNDX) PT Lowered to $36 00 at Stifel Nicolaus themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a research note published on Thursday morning. The brokerage issued a sell rating on the stock. Several other equities analysts have also commented on the stock. HC Wainwright raised their target price on shares of Syndax Pharmaceuticals from $38.00 to $42.00 and […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price target cut by equities researchers at Robert W. Baird from $32.00 to $28.00 in a research note issued on Tuesday, FlyOnTheWall reports. Robert W. Baird’s price target would suggest a potential upside of 107.41% from the stock’s current price. SNDX has been the subject of […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price target hoisted by investment analysts at Guggenheim from $42.00 to $43.00 in a note issued to investors on Tuesday, FlyOnTheWall reports. Guggenheim’s target price suggests a potential upside of 218.52% from the stock’s current price. SNDX has been the subject of a number of other […]